032: Genome alterations defining the metastatically relevant cancer cell

HIPO Investigator:

Prof. Allgayer

Mohammed Abba

Prof. Lichter

Prof. Eils

Dr. Christine Hauser

Dr. Nitin Patil

Dr. Olga Oleksiuk

Supported by: HIPO/POP

Entity: colorectal cancer and metastases


Abba ML et al.; Prevention of carcinogenesis and metastasis by Artemisinin-type drugs; Cancer Lett. 2018 (together with H027)

Abba M et al.; MicroRNAs as novel targets and tools in cancer therapy, Cancer Letters 2017

El-Daly SM et al., miRs-134 and -370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling; Sci. Rep. 2016

Bohlander PR et al.; Two wavelength-shifting molecular beacons for simultaneous and selective imaging of vesicular miRNA-21 and miRNA-31 in living cancer cells, Organic and Biomolecular Chemistry 2016

Abba M et al.; MicroRNA Regulation of Epithelial to Mesenchymal Transition; Journal of Clinical Medicine 2016

Abba M et al.; MicroRNAs — from metastasis prediction to metastasis prevention?; Mol Cell Oncol 2015

Oleksiuk O et al.; Single-Molecule Localization Microscopy allows for the analysis of cancer metastasis-specific miRNA distribution on the nanoscale; Oncotarget 2015

Mudduluru G. et al.; A Systematic Approach to Defining the microRNA Landscape in Metastasis; Cancer Res. 2015

Rusek AM et al.; MicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancer, Molecular Cancer 2015

Utikal J et al.; MicroRNAs in benign and malignant human stem cells; Seminars in Cancer Biology 2015

Abba M et al.; Differentially expressed microRNAs in colorectal cancer metastasis; Genomics Data 2015

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok Decline